Posted on 5월 22, 20235/22/23
Patient Assistance for Gene Therapies
Posted on 5월 19, 20235/19/23
The IDeaS Initiative: Pilot Study to Assess the Impact of Rare Diseases on Patients and Healthcare Systems
Posted on 5월 9, 20235/9/23
From Limitations to Expansions: How Prioritizing Patients’ Speed to Therapy Drives Therapy Adoption
Posted on 2월 21, 20232/21/23
Critical Success Factors for Launching Products with Orphan Drug Designation
Posted on 7월 27, 20227/27/22
EVERSANA’s Continued Commitment to Rare Disease
Posted on 5월 6, 20225/6/22
Case Study: Defining the Rare Disease Patient Journey to Support Commercialization of Therapy
Posted on 4월 14, 20224/14/22
Impact of Patient Reported Outcome Measures on HTA Decisions for Rare Diseases
Posted on 4월 8, 20224/8/22
EVERSANA Featured in NIH Study Detailing the Cost of Treating Rare Disease
Posted on 3월 11, 20223/11/22